A team of researchers at the National Institutes of Health (NIH) have unveiled new details about the events GLP-1 receptor agonists trigger within neurons, which have been largely unexplored until now. A study in mice identified ...
May 22, 2026
0
15
Obesity affects far more than metabolism and fat storage. It alters immune activity, nerve structure, and tissue organization across multiple organ systems, increasing the risk of diseases including type 2 diabetes, cardiovascular ...
May 20, 2026
0
75
Obesity is commonly diagnosed using BMI, but this approach has several limitations. Researchers at Lund University and AstraZeneca show that integrating measurements such as body fat percentage and waist circumference captures ...
May 19, 2026
1
11
In November 2025, the White House announced pricing deals with multiple pharmaceutical manufacturers to lower domestic prices for glucagon-like peptide-1 receptor agonist drugs (GLP-1RAs) including Ozempic, Wegovy, Mounjaro, ...
May 18, 2026
0
9
A research team from the School of Public Health at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has found that brisk interval walking performed once a week can significantly improve body fat reduction ...
May 12, 2026
0
28
A new study offers fresh insight into Alzheimer's disease by looking beyond the brain and focusing on metabolic health, particularly obesity. The Houston Methodist-led study moves beyond the traditional view of obesity as ...
May 11, 2026
0
14
A study has found that an emerging class of GLP-1 weight-loss drugs suppresses eating for pleasure, or hedonic feeding, in mice by modulating a reward circuit deep within the brain. This newly charted pathway—separate from ...
May 6, 2026
0
11
Glucagonlike peptide-1 (GLP-1) medications have taken over the national conversation around weight loss. From celebrity headlines to everyday conversations, GLP-1 drugs like Ozempic and Wegovy are often framed as breakthroughs ...
May 4, 2026
0
77
A team led by metabolism researcher Prof Timo D. Müller at Helmholtz Munich has developed a new approach for treating obesity and type 2 diabetes: a hybrid molecule uses the well-known GLP-1/GIP signaling pathway as a "door ...
Apr 29, 2026
0
18
People who live with obesity are "tagging" a memory of being overweight on a key part of the immune system—leaving people with ongoing risk of obesity-related conditions years after losing weight, according to a 10-year-long ...
Apr 27, 2026
0
18
